为开发抗疟疾药物,针对Plasmodium Vivax的抗疟原蛋白酶抑制剂的计算识别

Muharib Alruwaili1, Hassan H Alhassan1, Hayfa Almutary2

  • 1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Al-Jouf, 72388, Saudi Arabia.

Scientific reports
|April 28, 2025
PubMed
概括

这项研究通过向阿斯巴拉特蛋白酶,确定了有希望的新型抗疟疾化合物. CMNPD229显示出最稳定和潜力作为一种新型药物候选对抗疟疾寄生虫.